CCR7 and diffuse large B-cell lymphoma: For instance, CCR7 has been identified as a B-cell homeostatic chemokine receptor [21] and an independent prognostic marker in DLBCL patients [11], while studies by Uhl et al. [8] have shown no significant correlation between other chemokine receptors and patient survival, aside from CCR7.